Stealth Security recognized for being innovative, impactful, and intriguing in application and data security MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–May 10, 2018– Stealth Security, an innovator in the ...
"We appreciate FDA's recent recognition of the seriousness of Barth syndrome and the unmet need for potential therapies, and its commitment to complete its review of our NDA resubmission as ...
After an FDA rejection in May, Stealth BioTherapeutics has resubmitted a new drug application for its investigational treatment designed to treat an ultra-rare genetic disease. This is the biotech’s ...
AppOrbit, a startup founded by VMware and IBM veterans, came out of stealth Monday with an application modernization platform geared for enterprises looking to avoid costly redevelopment projects. The ...
It was a bold strategy, filing a drug the FDA clearly said was not ready for prime time, but Stealth BioTherapeutics did it anyway. Today, its chickens have come home to roost. The FDA has rejected ...
NEEDHAM, Mass., Aug. 18, 2025 /PRNewswire/ -- Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results